You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 18, May 12, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Complementary and Alternative Medicine
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethical Issues in Research in Complementary and Alternative Medicine

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their Special Communication, Dr Miller and colleagues1 stressed the need for studies that can identify whether complementary and alternative medicine (CAM) treatments produce clinically valuable placebo effects. They argued that such studies should control for the natural progression of disease, and should use objective rather than subjective outcomes.

We disagree with the authors, however, that trial designs must include both placebo-control and no-treatment arms to demonstrate placebo effects. Rather, we propose a simpler design, comprising 2 parallel, blinded trials with different proportions of participants randomized to active-treatment and placebo groups in each of the 2 trials. Participants would be informed of these proportions during informed consent, and thus those in the trial with a higher likelihood of receiving treatment would have higher expectations regarding their probable outcomes. If CAM has placebo effects, participants randomized to active-treatment and placebo groups in the trial in which a higher . . . [Full Text of this Article]

Harvey E. Cantor, MD
Department of Neurology
St Louis University School of Medicine
St Louis, Mo

Anup Malani, JD, PhD
amalani@virginia.edu
University of Virginia Law School
Charlottesville



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Ethical Issues in Research in Complementary and Alternative Medicine
Wayne B. Jonas, Christine Goertz, John Ives, Ronald A. Chez, and Harald Walach
JAMA. 2004;291(18):2192.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Ted J. Kaptchuk and Anthony Lembo
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Matko Marusic
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Paul J. Millea
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine—Reply
Franklin G. Miller, Ezekiel J. Emanuel, Donald L. Rosenstein, and Stephen E. Straus
JAMA. 2004;291(18):2193-2194.
EXTRACT | FULL TEXT  

Ethical Issues Concerning Research in Complementary and Alternative Medicine
Franklin G. Miller, Ezekiel J. Emanuel, Donald L. Rosenstein, and Stephen E. Straus
JAMA. 2004;291(5):599-604.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.